FDA Approved Medical Products for:

Congenital antithrombin deficiency

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Recombinant human antithrombin
Trade Name
(Manufacturer Name)
Atryn®
(GTC Biotherapeutics, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.
More Information about this product Drug Information Portal